1251714

Glaukos Corporation — FEI 3012341472

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Clemente, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)